KMT2C not only may act as a tumor suppressor in leukemias and T-cell lymphomas,75, 76but it is also implicated in bladder, breast, colorectal, endometrial, gastric, head and neck, lung, and liver cancer, and in medulloblastoma.108. Here, KMT2C is linked to T-cell non-Hodgkin lymphoma.